XPH ETF
State Street SPDR S&P Pharmaceuticals ETF
XPH ETF Overview
XPH ETF (State Street SPDR S&P Pharmaceuticals ETF) is managed by State Street Investment Management with $524.4M in net assets. XPH expense ratio is 0.35%, holding 67 positions across sectors including Health Care, Consumer Staples, Industrials. Inception date: 2006-06-19.
XPH performance shows a YTD return of 21.44%. The 1-year return is 65.77% and the 5-year return is 7.52%. XPH dividend yield stands at 0.49%, paid quarterly.
XPH top holdings include Definium Therapeutics, Inc. Common Shares (2.9%), Mbx Biosciences Inc (2.8%), Alumis Inc Common Stock USD 0.0001 (2.0%), Enliven Therapeutics Inc (2.0%), Trevi Therapeutics Inc. (2.0%). Go to all XPH holdings, XPH sectors, or XPH dividends.
XPH can be compared against other funds. Use XPH overlap to find shared positions, or XPH vs another fund for a side-by-side view. XPH alternatives are available via the screener, along with tax-loss harvesting opportunities.